Antibodies against donor human leukocyte antigens and the outcome of cardiac allografts in adults and children

Peter Stastny, Bhavna Lavingia, David E Fixler, Clyde W. Yancy, W Steves Ring

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

BACKGROUND. Mismatched histocompatibility antigens between donor organ and host stimulate the immune response that causes allograft rejection. Antibodies against human leukocyte antigen (HLA) are known to appear in the serum of heart transplant recipients. METHODS. We have tested stored sera with HLA bound to polystyrene microbeads in a retrospective analysis of heart recipients transplanted in our center to better understand the impact of antibodies against HLA on the posttransplant course. Our analysis included two groups of patients: 113 adults and 31 children who received consecutive heart transplants performed between 1996 and 2003. RESULTS. Presence of HLA antibodies, especially when donor-specific, as determined with single HLA class I or class II beads, was associated with more frequent occurrence of acute rejection, development of transplant-related coronary artery disease and decreased graft survival. Recipients having antibodies only to HLA not in the transplant and those without any HLA antibodies had similar outcomes, suggesting that antibodies against antigens not present on the donor organ did not harm the graft. CONCLUSION. The results showed that presence of antibodies against HLA of the donor correlated with graft loss and suggested that testing for these antibodies may help in the management of heart transplant patients.

Original languageEnglish (US)
Pages (from-to)738-745
Number of pages8
JournalTransplantation
Volume84
Issue number6
DOIs
StatePublished - Sep 2007

Fingerprint

HLA Antigens
Allografts
Antibodies
Transplants
Tissue Donors
Histocompatibility Antigens
Polystyrenes
Graft Rejection
Graft Survival
Serum
Microspheres
Coronary Artery Disease
Antigens

Keywords

  • Heart transplantation
  • Human leukocyte antigen antibodies
  • Single antigen beads

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Antibodies against donor human leukocyte antigens and the outcome of cardiac allografts in adults and children. / Stastny, Peter; Lavingia, Bhavna; Fixler, David E; Yancy, Clyde W.; Ring, W Steves.

In: Transplantation, Vol. 84, No. 6, 09.2007, p. 738-745.

Research output: Contribution to journalArticle

@article{c6a918c43a9b4df68fc48c51ba2764e5,
title = "Antibodies against donor human leukocyte antigens and the outcome of cardiac allografts in adults and children",
abstract = "BACKGROUND. Mismatched histocompatibility antigens between donor organ and host stimulate the immune response that causes allograft rejection. Antibodies against human leukocyte antigen (HLA) are known to appear in the serum of heart transplant recipients. METHODS. We have tested stored sera with HLA bound to polystyrene microbeads in a retrospective analysis of heart recipients transplanted in our center to better understand the impact of antibodies against HLA on the posttransplant course. Our analysis included two groups of patients: 113 adults and 31 children who received consecutive heart transplants performed between 1996 and 2003. RESULTS. Presence of HLA antibodies, especially when donor-specific, as determined with single HLA class I or class II beads, was associated with more frequent occurrence of acute rejection, development of transplant-related coronary artery disease and decreased graft survival. Recipients having antibodies only to HLA not in the transplant and those without any HLA antibodies had similar outcomes, suggesting that antibodies against antigens not present on the donor organ did not harm the graft. CONCLUSION. The results showed that presence of antibodies against HLA of the donor correlated with graft loss and suggested that testing for these antibodies may help in the management of heart transplant patients.",
keywords = "Heart transplantation, Human leukocyte antigen antibodies, Single antigen beads",
author = "Peter Stastny and Bhavna Lavingia and Fixler, {David E} and Yancy, {Clyde W.} and Ring, {W Steves}",
year = "2007",
month = "9",
doi = "10.1097/01.tp.0000281918.51138.3f",
language = "English (US)",
volume = "84",
pages = "738--745",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Antibodies against donor human leukocyte antigens and the outcome of cardiac allografts in adults and children

AU - Stastny, Peter

AU - Lavingia, Bhavna

AU - Fixler, David E

AU - Yancy, Clyde W.

AU - Ring, W Steves

PY - 2007/9

Y1 - 2007/9

N2 - BACKGROUND. Mismatched histocompatibility antigens between donor organ and host stimulate the immune response that causes allograft rejection. Antibodies against human leukocyte antigen (HLA) are known to appear in the serum of heart transplant recipients. METHODS. We have tested stored sera with HLA bound to polystyrene microbeads in a retrospective analysis of heart recipients transplanted in our center to better understand the impact of antibodies against HLA on the posttransplant course. Our analysis included two groups of patients: 113 adults and 31 children who received consecutive heart transplants performed between 1996 and 2003. RESULTS. Presence of HLA antibodies, especially when donor-specific, as determined with single HLA class I or class II beads, was associated with more frequent occurrence of acute rejection, development of transplant-related coronary artery disease and decreased graft survival. Recipients having antibodies only to HLA not in the transplant and those without any HLA antibodies had similar outcomes, suggesting that antibodies against antigens not present on the donor organ did not harm the graft. CONCLUSION. The results showed that presence of antibodies against HLA of the donor correlated with graft loss and suggested that testing for these antibodies may help in the management of heart transplant patients.

AB - BACKGROUND. Mismatched histocompatibility antigens between donor organ and host stimulate the immune response that causes allograft rejection. Antibodies against human leukocyte antigen (HLA) are known to appear in the serum of heart transplant recipients. METHODS. We have tested stored sera with HLA bound to polystyrene microbeads in a retrospective analysis of heart recipients transplanted in our center to better understand the impact of antibodies against HLA on the posttransplant course. Our analysis included two groups of patients: 113 adults and 31 children who received consecutive heart transplants performed between 1996 and 2003. RESULTS. Presence of HLA antibodies, especially when donor-specific, as determined with single HLA class I or class II beads, was associated with more frequent occurrence of acute rejection, development of transplant-related coronary artery disease and decreased graft survival. Recipients having antibodies only to HLA not in the transplant and those without any HLA antibodies had similar outcomes, suggesting that antibodies against antigens not present on the donor organ did not harm the graft. CONCLUSION. The results showed that presence of antibodies against HLA of the donor correlated with graft loss and suggested that testing for these antibodies may help in the management of heart transplant patients.

KW - Heart transplantation

KW - Human leukocyte antigen antibodies

KW - Single antigen beads

UR - http://www.scopus.com/inward/record.url?scp=34748843206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34748843206&partnerID=8YFLogxK

U2 - 10.1097/01.tp.0000281918.51138.3f

DO - 10.1097/01.tp.0000281918.51138.3f

M3 - Article

C2 - 17893607

AN - SCOPUS:34748843206

VL - 84

SP - 738

EP - 745

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 6

ER -